| Literature DB >> 29403771 |
Eman S Elzanfaly1, Ahmed S Saad1, Abd Elaziz B Abd Elaleem1.
Abstract
A new simple spectrophotometric method was developed for the simultaneous determination of drugs with interfering spectra in binary mixtures without previous separation. The new method is based on a simple modification for the ratio subtraction method. This modification enabled wider range of application. The proposed ratio difference method was applied for the determination of brimonidine and timolol in laboratory prepared mixtures with mean percentage recoveries 100.40±2.29 and 101.23±1.30 respectively, and in their pharmaceutical formulation with mean percentage recoveries 101.08±0.44 and 100.66±0.52 respectively. The suggested ratio difference method was validated according to USP guidelines and can be applied for routine quality control testing.Entities:
Keywords: Binary mixtures; Brimonidine; Ratio difference; Spectrophotometry; Timolol
Year: 2012 PMID: 29403771 PMCID: PMC5760779 DOI: 10.1016/j.jpha.2012.04.004
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Figure 1The ratio spectrum of 20 μg/mL Br (——), 50 μg/mL Ti (- - -) and a mixture containing 20 μg/mL Br and 50 μg/mL Ti (⋯) using a divisor of 50 μg/mL Ti in distilled water.
Figure 2The ratio spectrum of 20 μg/mL Br (——), 50 μg/mL Ti (- - -) and a mixture containing 20 μg/mL Br and 50 μg/mL Ti (⋯) using a divisor of 20 μg/mL Br in distilled water.
Figure 3The absorption spectra of 20 μg/mL Br (——) and 50 μg/mL Ti (- - -) in distilled water.
Determination of Br and Ti in laboratory prepared mixtures by the proposed ratio difference method.
| Concentration (μg/mL) | Recovery (%) | ||
|---|---|---|---|
| Br | Ti | Br Δ | Ti Δ |
| 10.00 | 50.00 | 96.52 | 101.06 |
| 20.00 | 20.00 | 100.75 | 101.42 |
| 20.00 | 40.00 | 100.43 | 102.53 |
| 20.00 | 50.00 | 100.82 | 101.23 |
| 25.00 | 30.00 | 103.33 | 102.26 |
| 30.00 | 50.00 | 99.58 | 98.87 |
| Mean | 100.40 | 101.23 | |
| Std | 2.29 | 1.30 | |
| RSD | 2.28 | 1.28 | |
Determination of Br and Ti in Combigan® eye drops by the proposed ratio difference method and application of standard addition technique.
| Product in Combigan® eye drop | Standard addition | Recovery (mean±SD, %) | ||||
|---|---|---|---|---|---|---|
| Taken (μg/mL) | Added (μg/mL) | Found (μg/mL) | Recovery (%) | Proposed method | Standard addition | |
| Br | 10.00 | 5.00 | 4.93 | 98.60 | 101.08±0.44 | 100.10±1.41 |
| 10.00 | 10.14 | 101.40 | ||||
| 20.00 | 20.06 | 100.30 | ||||
| Ti | 25.00 | 20.00 | 20.15 | 100.75 | 100.66±0.52 | 100.42±0.68 |
| 25.00 | 24.91 | 99.64 | ||||
| 30.00 | 30.26 | 100.87 | ||||
Combigan® eye drops, batch no. E62201 labeled to contain 2 mg/mL of brimonidine tartarate and 5 mg/mL of timolol.
Assay validation sheet of the proposed ratio difference method for the determination of Br and Ti.
| Parameter | Br | Ti |
|---|---|---|
| Accuracy (mean±SD) | 100.16±1.32 | 100.17±1.66 |
| Specificity | 100.40±2.29 | 101.23±1.30 |
| Precision | ||
| Repeatability | 100.21±0.73 | 100.06±0.32 |
| Intermediate precision | 100.07±0.40 | 100.09±0.39 |
| Linearity | ||
| Slope | 0.0762 | 0.0811 |
| Intercept | 0.1105 | 0.0780 |
| Correlation coefficient | 0.9999 | 0.9998 |
| Range (μg/mL) | 5–30 | 10–60 |
The intraday (n=3), average of three concentrations (10, 15 and 20 μg/mL) for Br and (20, 30 and 40 μg/mL) for Ti repeated three times within the day.
The interday (n=3), average of three concentrations (10, 15 and 20 μg/mL) for Br and (20, 30 and 40 μg/mL) for Ti repeated three times on three consecutive days.